Insights & Analysis

Industry insights that are curated and delivered to inform your dealmaking strategies. We select the most relevant information, providing a consistent, convenient source for exclusive intelligence and analysis.

All News Activism M&A Podcasts Private Cos. Private Equity Restructuring Scoops & Exclusives SPACs

Page 75

M&A

Discipline Crucial in 2020

By Alexandra Garfinkle
|
Published: December 2nd, 2019
M&A valuations remain frothy and Ebitda adjustments are growing, panelists cautioned at The 2019 Deal Economy Conference.
Activism

Vitamin Shoppe to Emphasize Organic Growth

By Alexandra Garfinkle
|
Published: December 2nd, 2019
Vitamin Shoppe GC David Kastin said that the company will pursue organic growth, while its soon-to-be parent pursues M&A.
Activism

Activists Find New Routes to M&A Opportunities

By Ronald Orol
|
Published: December 2nd, 2019
Insurgent managers are targeting larger companies and are taking on different roles, a panel of experts told The Deal Economy's 2019 conference.
Private Equity

PE Pros Talk Deal Pipeline

By Armie Margaret Lee
|
Published: December 2nd, 2019
Eurazeo's Vivianne Akriche told attendees at The Deal Economy conference on Wednesday that the pipeline is 'pretty full' for next year.
Activism

ESG Not Just a PC Term

By Greg Morcroft
|
Published: December 2nd, 2019
Corporations struggling to adapt to an investment community increasingly focused on improving environmental, social, and governance behavior may instead be missing an opportunity, according to a panel discussion at the Deal Economy Conference.
Activism

M&A, Politics, SEC Top of Mind for Activists

By Ronald Orol
|
Published: December 2nd, 2019
Schulte Roth partner Aneliya Crawford discusses activism at large-cap companies, BMY-Celgene and insurgent prospects in a second Trump or Warren administration at The Deal Economy conference.
M&A

Pfizer Leans Toward Tuck-In Deals

By Armie Margaret Lee
|
Published: November 27th, 2019
This year, Pfizer’s first under the leadership of Albert Bourla, the biopharma company has done deals including the purchase of Array BioPharma and Therachon.
Activism

Lawyers Debate Icahn-Oxy Feud

By Greg Morcroft
|
Published: November 27th, 2019
Sidley's Kai Liekefett and Schulte's Ele Klein diverge in their opinions about Carl Icahn’s unyielding agitation at Occidental Petroleum.
 Company
Solutions
Contact The Deal
Tel:
1-888-667-3325
International:
+1-212-224-3069
Email:
[email protected]
© 2025 The Deal.

A With Intelligence company. All rights reserved. Privacy Policy, Cookies, Terms, Modern Slavery Act